JPH052018A - Oxygen immunity dyeing method - Google Patents
Oxygen immunity dyeing methodInfo
- Publication number
- JPH052018A JPH052018A JP15202691A JP15202691A JPH052018A JP H052018 A JPH052018 A JP H052018A JP 15202691 A JP15202691 A JP 15202691A JP 15202691 A JP15202691 A JP 15202691A JP H052018 A JPH052018 A JP H052018A
- Authority
- JP
- Japan
- Prior art keywords
- phosphoric acid
- oxygen
- acid derivative
- peroxide
- triaminobenzene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 27
- 239000001301 oxygen Substances 0.000 title abstract 4
- 229910052760 oxygen Inorganic materials 0.000 title abstract 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 title abstract 3
- 238000004043 dyeing Methods 0.000 title abstract 2
- 230000036039 immunity Effects 0.000 title abstract 2
- AFINAILKDBCXMX-PBHICJAKSA-N (2s,3r)-2-amino-3-hydroxy-n-(4-octylphenyl)butanamide Chemical compound CCCCCCCCC1=CC=C(NC(=O)[C@@H](N)[C@@H](C)O)C=C1 AFINAILKDBCXMX-PBHICJAKSA-N 0.000 claims abstract description 14
- -1 aromatic amino compound Chemical class 0.000 claims abstract description 12
- JSYBAZQQYCNZJE-UHFFFAOYSA-N benzene-1,2,4-triamine Chemical compound NC1=CC=C(N)C(N)=C1 JSYBAZQQYCNZJE-UHFFFAOYSA-N 0.000 claims abstract description 10
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 claims abstract description 8
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 claims abstract description 7
- 102000004190 Enzymes Human genes 0.000 claims description 24
- 108090000790 Enzymes Proteins 0.000 claims description 24
- 238000012744 immunostaining Methods 0.000 claims description 13
- 239000002253 acid Substances 0.000 claims description 4
- 239000000126 substance Substances 0.000 abstract description 26
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 abstract description 16
- 238000004040 coloring Methods 0.000 abstract description 13
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 11
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract description 6
- 238000001514 detection method Methods 0.000 abstract description 6
- 238000006243 chemical reaction Methods 0.000 abstract description 4
- 150000002978 peroxides Chemical class 0.000 abstract description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract description 3
- 150000003839 salts Chemical class 0.000 abstract description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract description 2
- 238000003745 diagnosis Methods 0.000 abstract description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- 239000003513 alkali Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 27
- 229940088598 enzyme Drugs 0.000 description 22
- 102000013415 peroxidase activity proteins Human genes 0.000 description 17
- 108040007629 peroxidase activity proteins Proteins 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 239000000975 dye Substances 0.000 description 12
- 239000003960 organic solvent Substances 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 238000007254 oxidation reaction Methods 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 230000009870 specific binding Effects 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 5
- 238000005538 encapsulation Methods 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- HWTAKVLMACWHLD-UHFFFAOYSA-N 2-(9h-carbazol-1-yl)ethanamine Chemical compound C12=CC=CC=C2NC2=C1C=CC=C2CCN HWTAKVLMACWHLD-UHFFFAOYSA-N 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 239000003125 aqueous solvent Substances 0.000 description 3
- 230000018044 dehydration Effects 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000006911 enzymatic reaction Methods 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 230000003617 peroxidasic effect Effects 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 108090001008 Avidin Proteins 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 206010007269 Carcinogenicity Diseases 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 229930186217 Glycolipid Natural products 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 102000004856 Lectins Human genes 0.000 description 2
- 108090001090 Lectins Proteins 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 231100000260 carcinogenicity Toxicity 0.000 description 2
- 230000007670 carcinogenicity Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000011532 immunohistochemical staining Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000002523 lectin Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 150000001451 organic peroxides Chemical class 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000007447 staining method Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 description 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- LVSPDZAGCBEQAV-UHFFFAOYSA-N 4-chloronaphthalen-1-ol Chemical compound C1=CC=C2C(O)=CC=C(Cl)C2=C1 LVSPDZAGCBEQAV-UHFFFAOYSA-N 0.000 description 1
- OXEUETBFKVCRNP-UHFFFAOYSA-N 9-ethyl-3-carbazolamine Chemical compound NC1=CC=C2N(CC)C3=CC=CC=C3C2=C1 OXEUETBFKVCRNP-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 235000005956 Cosmos caudatus Nutrition 0.000 description 1
- 108060006006 Cytochrome-c peroxidase Proteins 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 206010073306 Exposure to radiation Diseases 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 108010023244 Lactoperoxidase Proteins 0.000 description 1
- 102100038609 Lactoperoxidase Human genes 0.000 description 1
- 108090000235 Myeloperoxidases Proteins 0.000 description 1
- 102000003896 Myeloperoxidases Human genes 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- SXEHKFHPFVVDIR-UHFFFAOYSA-N [4-(4-hydrazinylphenyl)phenyl]hydrazine Chemical compound C1=CC(NN)=CC=C1C1=CC=C(NN)C=C1 SXEHKFHPFVVDIR-UHFFFAOYSA-N 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 230000002494 anti-cea effect Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- RUOKPLVTMFHRJE-UHFFFAOYSA-N benzene-1,2,3-triamine Chemical compound NC1=CC=CC(N)=C1N RUOKPLVTMFHRJE-UHFFFAOYSA-N 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 238000009739 binding Methods 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000008393 encapsulating agent Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 229940057428 lactoperoxidase Drugs 0.000 description 1
- 150000002641 lithium Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、生体組成媒体の酵素免
疫染色法に関し、特に有機溶媒などに難溶な色素を構成
する酵素免疫染色法に関するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an enzyme immunostaining method for a biological composition medium, and more particularly to an enzyme immunostaining method for forming a dye that is poorly soluble in an organic solvent.
【0002】[0002]
【発明の背景】臨床学的解析を確実、かつ、簡便に行う
必要から生体成分などの特定成分を検出する各種の分析
法が開発されて来ている。これらの方法のうち、最も精
度の高い方法として、特定成分とこれに対して特異的に
結合しうる物質(以後、特異結合物質)、例えば抗原と
抗体、ある種の糖鎖とレクチン、ビオチンとアビジン、
プロテインAとIgG、ホルモンとレセプタ、酵素と基
質などの間の特異的結合反応を用いる方法が知られてい
る。BACKGROUND OF THE INVENTION Various analytical methods for detecting specific components such as biological components have been developed because it is necessary to perform clinical analysis reliably and easily. Of these methods, the most accurate method is to use a specific component and a substance that can specifically bind to it (hereinafter, a specific binding substance), such as an antigen and an antibody, a certain sugar chain and a lectin, and biotin. Avidin,
Methods using a specific binding reaction between protein A and IgG, hormone and receptor, enzyme and substrate, etc. are known.
【0003】一般的には、何らかの標識を付した特異結
合物質(以後、標識体)を用い、対象とする特定成分に
応じて変化した該標識体のシグナルを検出することによ
り特定成分の測定が行われる。特に、マトリックス媒体
に直接的または間接的に担持させた特定成分を標識体と
反応させ、両者の複合体として標識体を固定し、実質的
に特定成分に応じた標識からのシグナルを検出する方法
が適宜用いられる。In general, a specific binding substance (hereinafter referred to as a labeled substance) labeled with some kind of label is used, and the specific component can be measured by detecting the signal of the labeled substance which varies according to the specific component of interest. Done. In particular, a method of reacting a specific component directly or indirectly supported on a matrix medium with a label, immobilizing the label as a complex of both and detecting a signal from the label substantially corresponding to the specific component. Is used as appropriate.
【0004】例えば、電気泳動した蛋白質生体成分(特
定成分)をゲルからニトロセルロース膜上に転写して担
持し、これを標識体、例えば抗体標識体と反応させ、シ
グナルを検出する方法、TLCプレート上に展開した脂
質等の特定成分に標識体を反応させてシグナルを検出す
る方法、膜上でDNAに対して標識した相補的DNAと
を反応させ、シグナルを検出する方法あるいは免疫組織
染色法などである。For example, a method for transferring a biological component (specific component) of an electrophoresed protein from a gel onto a nitrocellulose membrane and supporting it, and reacting this with a label, for example, an antibody label, and detecting a signal, TLC plate A method of detecting a signal by reacting a labeled substance with a specific component such as a lipid developed on the above, a method of detecting a signal by reacting with complementary DNA labeled to DNA on a membrane, an immunohistological staining method, etc. Is.
【0005】免疫組織染色法においては、組織上の目的
とする特定成分の存在場所、状態などの情報が得られ
る。特異結合物質の標識としては、従来、放射性同位元
素、螢光物質、発光物質、酵素などが用いられている。
これらのうち放射性同位元素を用いた場合は放射活性の
減衰や廃棄、被曝あるいは設備に巨費を要し、更に長い
時間と煩雑な操作を要するという欠点がある。又、螢光
物質もしくは発光物質を用いる場合は、特殊な装置や設
備が必要になる。一方、酵素を用いた場合、操作も比較
的簡単で、生成色素はたやすく可視化でき、特定成分の
定量も可能である。従来、このような標識酵素として、
ペルオキシダーゼ、アルカリフォスファターゼ、β−ガ
ラクトシダーゼ等が用いられてきた。特に、使用のし易
さ、安定性よりペルオキシダーゼが広く用いられてき
た。In the immunohistological staining method, information such as the location and state of the target specific component on the tissue can be obtained. Radiolabels, fluorescent substances, luminescent substances, enzymes and the like have been conventionally used as labels for specific binding substances.
Among these, the use of radioisotopes has the drawbacks that the decay of radioactivity, disposal, exposure to radiation, or equipment requires enormous cost, and further requires a long time and complicated operations. Further, when using a fluorescent substance or a luminescent substance, a special device or equipment is required. On the other hand, when an enzyme is used, the operation is relatively simple, the produced dye can be easily visualized, and the specific component can be quantified. Conventionally, as such a labeling enzyme,
Peroxidase, alkaline phosphatase, β-galactosidase and the like have been used. In particular, peroxidase has been widely used because of its ease of use and stability.
【0006】酵素免疫染色法、特に生成組織、細胞上の
抗原物質を検出、測定する免疫組織染色法は、診断上有
益な方法である。免疫組織染色法において常用される方
法としては、ペルオキシダーゼ(POD)の酸化触媒作
用によって色原体を酸化し、色素を生成して染色した
後、試料保存の為に、エタノール、キシレンで試料を洗
浄し、脱水後封入剤に浸漬し、封入が施される。[0006] The enzyme immunostaining method, particularly the immunohistostaining method for detecting and measuring the antigenic substances on the produced tissue and cells is a diagnostically useful method. As a method commonly used in the immunohistochemical staining method, the chromogen is oxidized by the oxidation catalytic action of peroxidase (POD) to produce a dye and stained, and then the sample is washed with ethanol and xylene for sample storage. Then, after dehydration, it is immersed in an encapsulant and encapsulated.
【0007】色原体としてはジアミノベンジジン(DA
B)、アミノエチルカルバゾール(AEC)が常用され
ている。前記のDABを用いると、染色色素はポリマー
化し、有機溶媒に不溶であり、封入には好都合である
が、これは発癌性物質であり、又、色調は黄ないしは褐
色であり、検出、診断に困難である。又、AECを用い
る場合には、染色色素は赤色であり、色調的には好都合
であるが、エタノール、キシレン等の有機溶媒に可溶で
あり、洗浄、脱水、封入操作が著しく困難であり、特殊
試薬を用い、煩雑な操作が強いられている。As a chromogen, diaminobenzidine (DA
B) and aminoethylcarbazole (AEC) are commonly used. When the above-mentioned DAB is used, the dye is polymerized and insoluble in an organic solvent, which is convenient for encapsulation, but it is a carcinogenic substance, and the color tone is yellow or brown, which is useful for detection and diagnosis. Have difficulty. When AEC is used, the dye is red, which is convenient in terms of color tone, but it is soluble in organic solvents such as ethanol and xylene, and washing, dehydration, and encapsulation operations are extremely difficult. Cumbersome operations are required using special reagents.
【0008】尚、一般的なペルオキシダーゼ酵素免疫染
色法については、色原体として芳香族アミン化合物に組
み合わせてフェノール化合物(特開昭63−6462号
公報)、あるいは活性メチレン化合物(特開昭63−7
1654号公報)を用いることが有用であることが開示
されているが、これらの染色色素も有機溶媒に可溶であ
り、封入、保存に支障がある。Regarding the general peroxidase enzyme immunostaining method, a phenol compound (JP-A 63-6462) or an active methylene compound (JP-A 63-462) is used in combination with an aromatic amine compound as a chromogen. 7
1654) is useful, but these dyes are also soluble in an organic solvent and have a problem in encapsulation and storage.
【0009】[0009]
【発明の開示】本発明の第1の目的は、安定性に優れた
酵素免疫染色法を提供することである。本発明の第2の
目的は、鮮明で、診断や検出が容易な酵素免疫染色法を
提供することである。DISCLOSURE OF THE INVENTION The first object of the present invention is to provide an enzyme immunostaining method having excellent stability. A second object of the present invention is to provide an enzyme immunostaining method which is clear and easy to diagnose and detect.
【0010】本発明の第3の目的は、発癌性などの危険
性がない酵素免疫染色法を提供することである。本発明
の第4の目的は、封入操作が簡単な酵素免疫染色法を提
供することである。上記本発明の目的は、オルトフェニ
レンジアミン、パラフェニレンジアミン、1,2,4−
トリアミノベンゼンの群の中から選ばれる芳香族アミン
化合物と縮合リン酸誘導体を用いることを特徴とする酵
素免疫染色法によって達成される。A third object of the present invention is to provide an enzyme immunostaining method which is free from the risk of carcinogenicity. A fourth object of the present invention is to provide an enzyme-linked immunostaining method with a simple encapsulation operation. The above-mentioned objects of the present invention are ortho-phenylenediamine, para-phenylenediamine, 1,2,4-
It is achieved by an enzyme immunostaining method characterized by using an aromatic amine compound selected from the group of triaminobenzene and a condensed phosphoric acid derivative.
【0011】尚、オルトフェニレンジアミン、パラフェ
ニレンジアミン、1,2,4−トリアミノベンゼンは酸
化されることにより色素を生成する色原体であり、これ
らは例えば塩酸塩のような塩の形のものであっても良
い。そして、縮合リン酸誘導体におけるリンの酸化数が
5のリン酸誘導体であるものが、特にウルトラリン酸又
はウルトラリン酸塩の群の中から選ばれるもの、最も望
ましくはウルトラリン酸アルカリ金属(ナトリウム、カ
リウム、リチウム)塩であるものが好ましい。Ortho-phenylenediamine, para-phenylenediamine, and 1,2,4-triaminobenzene are chromogens that produce dyes by being oxidized, and these are in the form of salts such as hydrochloride. It may be one. And, a phosphoric acid derivative having a phosphoric acid oxidation number of 5 in the condensed phosphoric acid derivative is particularly selected from the group of ultraphosphoric acid or ultraphosphate, and most preferably an alkali metal ultraphosphate (sodium). , Potassium, lithium) salts are preferred.
【0012】又、酵素(疑似酵素も含まれる)として
は、色原体(芳香族アミン化合物)を酸化し、解析手段
を与える反応を触媒するものであれば特に限定されない
が、過酸化酵素が好ましい。過酸化酵素又は過酸化疑似
酵素による酸化反応には過酸化物質が必要とされる。過
酸化物質としては、無機、有機いずれの過酸化物資、例
えば有機過酸化物質であっても良いが、過酸化水素が好
ましい。過酸化酵素としては、例えばホースラディッシ
ュペルオキシダーゼ、ラクトペルオキシダーゼ、ミエロ
ペルオキシダーゼ、グルタチオンペルオキシダーゼ、チ
トクロームCペルオキシダーゼ等が使用可能であり、ま
た過酸化疑似酵素としては、例えばヘモグロビンや鉄、
金、銀等の金属及び金属化合物が使用される。The enzyme (including a pseudoenzyme) is not particularly limited as long as it catalyzes a reaction that oxidizes a chromogen (aromatic amine compound) and provides an analysis means, but a peroxidase is preferable. A peroxidative substance is required for the oxidation reaction by a peroxidase or a peroxidative pseudoenzyme. The peroxide substance may be an inorganic or organic peroxide substance, for example, an organic peroxide substance, but hydrogen peroxide is preferable. As the peroxidase, for example, horseradish peroxidase, lactoperoxidase, myeloperoxidase, glutathione peroxidase, cytochrome C peroxidase or the like can be used, and as the peroxidative pseudoenzyme, for example, hemoglobin or iron,
Metals and metal compounds such as gold and silver are used.
【0013】発色試薬には、少なくとも酸化されること
により解析手段を与える色原体及びウルトラリン酸アル
カリ金属塩のような縮合リン酸誘導体が含まれていれば
良く、又、過酸化水素等の過酸化物質又は過酸化酵素が
含まれても良く、更に、必要に応じてその他の物質、例
えば安定化剤が含まれていていもよい。発色試薬として
は、固体状、粉末状、溶液状など種々の形態のものが含
まれ、これら固体状、粉末状、溶液状などの種々の形態
の発色試薬は適当な操作、例えば溶媒への溶解等によ
り、検出系に使用可能な溶液状の発色試薬液に調製が可
能である。 安定化の対象とする検出系は、前記酵素又
はその疑似酵素により前記色原体の酸化反応を行わせ、
その程度を例えば光学的手段により検出する系であり、
結果の解析により目的の情報、例えば酵素活性に対応し
た試料中の解析物質を得ることができる。一般に、その
酵素又は疑似酵素の酸化反応は色原体を溶解した溶液中
にて行われる。It is sufficient that the color-forming reagent contains at least a chromogen that gives an analysis means by being oxidized and a condensed phosphoric acid derivative such as an alkali metal salt of ultraphosphoric acid. It may contain a peroxide substance or a peroxidase, and may further contain other substances such as a stabilizer, if necessary. The color-forming reagent includes various forms such as solid, powder and solution.The color-forming reagent in various forms such as solid, powder and solution is subjected to an appropriate operation such as dissolution in a solvent. As described above, it is possible to prepare a coloring reagent solution in the form of a solution that can be used in the detection system. The detection system targeted for stabilization is to cause an oxidation reaction of the chromogen by the enzyme or its pseudoenzyme,
It is a system that detects the degree by optical means,
By analyzing the results, it is possible to obtain the target information, for example, the substance to be analyzed in the sample corresponding to the enzyme activity. Generally, the oxidation reaction of the enzyme or the pseudoenzyme is carried out in a solution in which the chromogen is dissolved.
【0014】発色試薬液又は検出系に用いる溶媒として
は水系溶媒が好ましいが、酵素的酸化反応を極端に阻害
するものでなければ、有機溶媒又は有機溶媒と水系溶媒
の混合溶媒であってもよい。一般には水、場合によって
は有機溶媒、例えばメタノール、エタノール、N,N−
ジメチルホルムアミド、ジメチルスルホキシド、N−メ
チルピロリドン、ジオキサンと水系溶媒の混合溶媒が用
いられる。溶媒は酵素反応に適当なpH値にあることが
望ましく、通常用いられる緩衝剤により調製されること
が好ましい。過酸化酵素を用いる場合は、pH3ないし
pH9が好ましい。The color reagent solution or the solvent used in the detection system is preferably an aqueous solvent, but may be an organic solvent or a mixed solvent of an organic solvent and an aqueous solvent as long as it does not extremely inhibit the enzymatic oxidation reaction. . Generally water, optionally organic solvents such as methanol, ethanol, N, N-
A mixed solvent of dimethylformamide, dimethylsulfoxide, N-methylpyrrolidone, dioxane and an aqueous solvent is used. It is desirable that the solvent has a pH value suitable for the enzymatic reaction, and it is preferable that the solvent is prepared by using a commonly used buffer. When using a peroxidase, pH 3 to pH 9 is preferred.
【0015】ウルトラリン酸アルカリ金属塩のような縮
合リン酸誘導体を発色試薬液に含有させるには、色原体
を溶解した溶媒に添加してもよく、溶媒に最初に溶解後
に色原体を添加してもよく、又、色原体と縮合リン酸誘
導体の混合物もしくは凍結乾燥物を同時に溶媒に添加、
溶解してもよい。又、色原体を含む溶液と縮合リン酸誘
導体を含む溶液を混合してもよい。In order to include a condensed phosphoric acid derivative such as an alkali metal salt of ultraphosphoric acid in the color reagent solution, it may be added to a solvent in which the chromogen is dissolved, and the chromogen is first dissolved in the solvent. It may be added, or the mixture of the chromogen and the condensed phosphoric acid derivative or the lyophilized product is simultaneously added to the solvent,
It may be dissolved. Further, the solution containing the chromogen and the solution containing the condensed phosphoric acid derivative may be mixed.
【0016】発色試薬液又は検出系において含有される
縮合リン酸誘導体の濃度は、酵素反応における阻害の程
度と非酵素的酸化の抑制度を考慮して決定されるが、
0.01ないし1000mM、望ましくは0.1ないし
500mM、より望ましくは1ないし100mMである
ことが好ましい。又、色原体の濃度は0.1ないし50
0mMが好ましい。The concentration of the condensed phosphoric acid derivative contained in the color reagent solution or the detection system is determined in consideration of the degree of inhibition in the enzyme reaction and the degree of inhibition of non-enzymatic oxidation.
It is preferably 0.01 to 1000 mM, preferably 0.1 to 500 mM, more preferably 1 to 100 mM. The chromogen concentration is 0.1 to 50.
0 mM is preferred.
【0017】例えば、0.1ないし500mMの濃度の
色原体及び0.01ないし1000mMの濃度の縮合リ
ン酸誘導体を含有させたpH3ないしpH9の緩衝液を
調製し、発色試薬液を用意する。発色試薬液と試料とを
混合し、2ないし50℃の温度で酵素反応を行わせ、一
定時間してから水洗等の処理により反応を停止させる。
試料中の過酸化酵素活性に応じて色原体が酸化され、そ
の結果生成した物質がマトリックス媒体上に決着し、こ
れを光学的に検出する。尚、生成色素は有機溶媒にも不
溶であり、免疫組織染色に適用可能である。For example, a pH 3 to pH 9 buffer solution containing a chromogen at a concentration of 0.1 to 500 mM and a condensed phosphoric acid derivative at a concentration of 0.01 to 1000 mM is prepared to prepare a color reagent solution. The color reagent solution and the sample are mixed, the enzyme reaction is carried out at a temperature of 2 to 50 ° C., and after a certain period of time, the reaction is stopped by a treatment such as washing with water.
The chromogen is oxidized in response to the peroxidase activity in the sample, and the resulting material settles on the matrix medium and is optically detected. The produced dye is insoluble in organic solvents and can be applied to immunohistological staining.
【0018】本発明において、測定の対象となる特定成
分は、その特定成分に特異的に結合する特異結合物質が
得られる物質または物質群である。例えば、蛋白質、核
酸、ホルモン、脂質、複合糖質、糖脂質、多糖類、酵
素、ビタミン、抗原、抗体などが挙げられる。本発明に
使用し得る特異結合物質は、特定成分又は他の特異結合
物質と特異的に結合できる物質であり、測定対象とする
特定成分に応じて適当に選ぶ事ができる。例えば、蛋白
質、核酸、ホルモン、脂質、複合糖質、糖脂質、多糖
類、酵素、ビタミン、抗原、抗体、レクチン、プロテイ
ンA、アビジン、ビオチン、レセプター、補酵素、酵素
の基質、毒素、補体及びこれらの複合体等が挙げられ
る。In the present invention, the specific component to be measured is a substance or a group of substances that gives a specific binding substance that specifically binds to the specific component. Examples thereof include proteins, nucleic acids, hormones, lipids, complex carbohydrates, glycolipids, polysaccharides, enzymes, vitamins, antigens, antibodies and the like. The specific binding substance that can be used in the present invention is a substance that can specifically bind to a specific component or another specific binding substance, and can be appropriately selected according to the specific component to be measured. For example, protein, nucleic acid, hormone, lipid, complex carbohydrate, glycolipid, polysaccharide, enzyme, vitamin, antigen, antibody, lectin, protein A, avidin, biotin, receptor, coenzyme, enzyme substrate, toxin, complement And composites thereof and the like.
【0019】本発明の酵素免疫染色法を適用し得るもの
としては、セルロースアセテートやニトロセルロース等
の膜、ポリアクリルアミド等のゲル状支持体、TLCプ
レート等のシリカゲル担体、デキストラン、アガロース
等の多糖類及びその誘導体、プレート状、ビーズ状のプ
ラスチック、ガラス、金属、繊維、活性炭、ヒドロキシ
アパタイト等のマトリックス媒体が挙げられる。尚、マ
トリックス媒体としては化学的に活性な基(例えば、−
SH、−NH2 、−COOH等の基)を有するものであ
ることが好ましい。又、免疫組織染色法においては組織
そのものに適用できる。The enzyme immunostaining method of the present invention can be applied to membranes such as cellulose acetate and nitrocellulose, gel supports such as polyacrylamide, silica gel carriers such as TLC plates, and polysaccharides such as dextran and agarose. And its derivatives, plate-like or bead-like plastics, glass, metals, fibers, activated carbon, matrix media such as hydroxyapatite. As a matrix medium, a chemically active group (for example, −
SH, —NH 2 , —COOH, etc.) are preferred. Further, the immunohistochemical staining method can be applied to the tissue itself.
【0020】[0020]
〔実施例1〕0.02%の過酸化水素を含有する100
mMクエン酸−リン酸緩衝液(pH5.0)と0.02
%の過酸化水素を含有する100mMウルトラリン酸
(関東化学社製、N2 P4 O11)緩衝液(pH5.0)
とを所望量混和し、次いで色原体を5mg/10mlと
なるように添加溶解し、下記の表1の発色液を調製し
た。Example 1 100 containing 0.02% hydrogen peroxide
mM citrate-phosphate buffer (pH 5.0) and 0.02
% Of 100mM ultra phosphoric acid containing hydrogen peroxide (manufactured by Kanto Chemical Co., Inc., N 2 P 4 O 11) buffer (pH 5.0)
And were mixed in a desired amount, and then the chromogen was added and dissolved at 5 mg / 10 ml to prepare a color developing solution shown in Table 1 below.
【0021】そして、0.5μgのペルオキシダーゼを
ブロットしたPVDF(ミリポア社製のポリビニルジフ
ロライド)膜を各発色液中に浸漬し、10分間反応後水
洗した。
表1
発色液 色原体 クエン酸緩衝液/ウルトラリン酸緩衝液
A−1 o−フェニレンジアミン 1/0
A−2 〃 0.98/0.02
A−3 〃 0.8/0.2
A−4 〃 0/1
B−1 p−フェニレンジアミン 1/0
B−2 〃 0.98/0.02
B−3 〃 0.8/0.2
B−4 〃 0/1
C−1 1.2.4−トリアミノベンゼン 1/0
C−2 〃 0.98/0.02
C−3 〃 0.8/0.2
C−4 〃 0/1
その結果、A−1、B−1、C−1の発色液が用いられ
た場合には、生成色素は水に溶解したが、その他は溶解
することなく、色素スポットが出現した。Then, a PVDF (polyvinyl difluoride manufactured by Millipore) membrane on which 0.5 μg of peroxidase was blotted was dipped in each color-developing solution, reacted for 10 minutes and washed with water. Table 1 Coloring liquid Chromogen Citrate buffer / Ultraphosphate buffer A-1 o-phenylenediamine 1/0 A-2 〃 0.98 / 0.02 A-3 〃 0.8 / 0.2 A -4 〃 0/1 B-1 p-phenylenediamine 1/0 B-2 〃 0.98 / 0.02 B-3 〃 0.8 / 0.2 B-4 〃 0/1 C-1 1. 2.4-triaminobenzene 1/0 C-2 〃 0.98 / 0.02 C-3 〃 0.8 / 0.2 C-4 〃 0/1 As a result, A-1, B-1, When the color developing solution of C-1 was used, the produced dye dissolved in water, but the others did not dissolve, and a dye spot appeared.
【0022】〔実施例2〕段階希釈したペルオキシダー
ゼをブロットしたPVDF膜を実施例1と同様のA−
3,B−3,C−3及び比較の発色液D中に浸漬し、1
0分間反応後水洗した。尚、比較の発色液Dは、3mg
の4−クロロ−1−ナフトールを1mlのメタノールに
溶解し、さらに0.024%過酸化水素含有トリス塩酸
緩衝液(pH7.4、200mM塩化ナトリウム含有)
5mlを加え、調整したものである。[Example 2] A PVDF membrane blotted with serially diluted peroxidase was treated with the same A-
3, B-3, C-3 and comparative coloring solution D
After reacting for 0 minutes, it was washed with water. The comparative coloring liquid D is 3 mg.
4-chloro-1-naphthol was dissolved in 1 ml of methanol, and 0.024% hydrogen peroxide-containing Tris-HCl buffer (pH 7.4, containing 200 mM sodium chloride)
It was prepared by adding 5 ml.
【0023】その結果は、A−3及びB−3のもので
は、0.2ngのペルオキシダーゼが、C−3のもので
は0.1ngのペルオキシダーゼが検出可能であったの
に対して、比較の発色液Dでは、1ngのペルオキシダ
ーゼが検出可能であるに過ぎなかった。又、得られたP
VDF膜を70%エタノール、純エタノールに順に浸漬
したところ、A−3、B−3、C−3の発色液が用いら
れた色素スポットは保持されたが、比較の発色液Dが用
いられた色素スポットは溶解、消滅した。As a result, 0.2 ng of peroxidase was detected in A-3 and B-3, and 0.1 ng of peroxidase was detected in C-3, whereas the color development of comparative color was detected. In liquid D, only 1 ng of peroxidase was detectable. Also, the obtained P
When the VDF film was sequentially immersed in 70% ethanol and pure ethanol, the dye spots using the color developing solutions A-3, B-3, and C-3 were retained, but the comparative color developing solution D was used. The dye spot dissolved and disappeared.
【0024】〔実施例3〕胃癌組織のパラフィン切片を
常法に従い10%ヤギ血清/PBS溶液にてブロッキン
グした後、抗CEAマウスモノクローナル抗体(コスモ
・バイオ社)と反応させた。15分後にPBSで洗浄
し、さらにペルオキシダーゼ標識ヤギ抗マウスイムノグ
ロブリン抗体(カッペル社)と反応させた。Example 3 A paraffin section of a gastric cancer tissue was blocked with a 10% goat serum / PBS solution according to a conventional method and then reacted with an anti-CEA mouse monoclonal antibody (Cosmo Bio Inc.). After 15 minutes, the plate was washed with PBS and further reacted with a peroxidase-labeled goat anti-mouse immunoglobulin antibody (Kappel).
【0025】15分後にPBSで洗浄した後、下記の発
色液中で10分間反応させた。
発色液A−5 o−フェニレンジアミンを2mg/ml
になるように0.02%過酸化水素含有の100mMウ
ルトラリン酸緩衝液(pH5.0)に溶解
発色液C−5 1.2.4−トリアミノベンゼンを2m
g/mlになるように0.02%過酸化水素含有の10
0mMウルトラリン酸緩衝液(pH5.0)に溶解
比較発色液E 5mgの3−アミノ−9−エチルカルバ
ゾールを1mlのDMFに溶解し、さらに0.02%過
酸化水素含有のトリス塩酸緩衝液(pH7.4)9ml
を加えて調整
10分間の反応後、水洗したところ、発色液A−5及び
発色液C−5が用いられたものでは黒褐色のCEA陽性
像が、比較発色液Eが用いられたものでは赤色のCEA
陽性像が顕微鏡下に見られた。After 15 minutes, the plate was washed with PBS and then reacted in the following coloring solution for 10 minutes. Coloring liquid A-5 o-phenylenediamine 2 mg / ml
Dissolve in a 100 mM ultraphosphate buffer (pH 5.0) containing 0.02% hydrogen peroxide so that the coloring solution C-5 1.2.4-triaminobenzene is 2 m.
10% containing 0.02% hydrogen peroxide to achieve g / ml
Dissolved in 0 mM ultraphosphate buffer (pH 5.0) Comparative coloring solution E 5 mg of 3-amino-9-ethylcarbazole was dissolved in 1 ml of DMF, and a tris-hydrochloric acid buffer solution containing 0.02% hydrogen peroxide ( pH 7.4) 9 ml
After the reaction for 10 minutes after adjustment, the product was washed with water, and a black-brown CEA-positive image was obtained in the case where the coloring solution A-5 and the coloring solution C-5 were used, and a red color was obtained in the case where the comparative coloring solution E was used. CEA
A positive image was visible under the microscope.
【0026】次いで、70%エタノールに3回、純エタ
ノールに3回、キシレンに3回浸漬させ、脱水透徹操作
を行ったところ、A−5及びC−5の発色液が用いられ
たものではCEA陽性像が見られたが、比較発色液Eが
用いられたものではCEA陽性像が消滅した。Then, the mixture was immersed in 70% ethanol three times, pure ethanol three times, and xylene three times to carry out a dehydration clearing operation. As a result, CEA was obtained in the case where the color developing solutions A-5 and C-5 were used. Although a positive image was seen, the CEA positive image disappeared in the case where the comparative color developing solution E was used.
【0027】[0027]
【効果】本発明は、安定性に優れ、しかも鮮明で、診断
や検出が容易なものであり、かつ、発癌性などの危険性
がなく、そして封入操作が簡単な酵素免疫染色法であ
る。[Effect] The present invention is an enzyme immunostaining method which is excellent in stability, clear, easy to diagnose and detect, has no risk of carcinogenicity, and has a simple encapsulation operation.
Claims (2)
レンジアミン、1,2,4−トリアミノベンゼンの群の
中から選ばれる芳香族アミン化合物と縮合リン酸誘導体
を用いることを特徴とする酵素免疫染色法。1. An enzyme immunostaining method comprising using an aromatic amine compound selected from the group consisting of orthophenylenediamine, paraphenylenediamine and 1,2,4-triaminobenzene and a condensed phosphoric acid derivative.
ウルトラリン酸塩であることを特徴とする請求項1の酵
素免疫染色法。2. The enzyme immunostaining method according to claim 1, wherein the condensed phosphoric acid derivative is ultraphosphoric acid or ultraphosphate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15202691A JPH052018A (en) | 1991-06-24 | 1991-06-24 | Oxygen immunity dyeing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15202691A JPH052018A (en) | 1991-06-24 | 1991-06-24 | Oxygen immunity dyeing method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH052018A true JPH052018A (en) | 1993-01-08 |
Family
ID=15531439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP15202691A Pending JPH052018A (en) | 1991-06-24 | 1991-06-24 | Oxygen immunity dyeing method |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH052018A (en) |
-
1991
- 1991-06-24 JP JP15202691A patent/JPH052018A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0171150B2 (en) | Method and apparatus for assaying with optional reagent quality control | |
| Zuk et al. | Enzyme immunochromatography--a quantitative immunoassay requiring no instrumentation. | |
| CA1104928A (en) | Oxidizing phenolic compounds in enzymatic immunoassay | |
| US4786589A (en) | Immunoassay utilizing formazan-prelabeled reactants | |
| US8383422B2 (en) | Immunochromatographic device | |
| EP0653637B1 (en) | Dry elements, test devices, test kits and methods for chemiluminescent detection of analytes using peroxidase labeled reagents | |
| JP2642342B2 (en) | Solid phase diffusion test method | |
| JP3715348B2 (en) | Analytical elements, compositions and methods using modified apopoperoxidase | |
| US5176999A (en) | Buffered wash composition, insolubilizing composition, test kits and method of use | |
| JPH0792460B2 (en) | Kit for detecting microorganisms associated with periodontal disease using surfactant mixture as extraction composition and method for detecting the same | |
| FI101830B (en) | Light-resistant, physical developer | |
| JPH052018A (en) | Oxygen immunity dyeing method | |
| US6159699A (en) | Enzyme linked chemiluminescent assay | |
| JP2549550B2 (en) | Method for measuring specific component using peroxidase enzymatic reaction | |
| JPS63209600A (en) | Measurement by peroxidase label | |
| JPH05505513A (en) | Luminescent or luminometric test | |
| JP3194446B2 (en) | Immunological detection method using electron carrier as labeling substance | |
| KR0151584B1 (en) | Method for detecting a specific binding substance in blood and also a test kit for carrying out said method | |
| JPH04128654A (en) | Enzyme immune dyeing method | |
| SU1656455A1 (en) | Method for determination of antibodies to catecholamine | |
| JPH01316660A (en) | Immunological detection of material and composition and test kit used therefor | |
| JPS58206966A (en) | Simultaneous calibration heterogeneous immunoassay | |
| JPH0783926A (en) | Peroxidase immunity dyeing method and stabilizing method for aroma group hydroxy compound solution | |
| JPH07218508A (en) | Blocking reagent and enzyme immuno-dyeing method of peroxydase marked body | |
| JPH0755807A (en) | Method for stabilizing chromogen solution and stabilized chromogen solution |